Captrust Financial Advisors Evolus, Inc. Transaction History

Captrust Financial Advisors

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$5.22 - $11.78 $5,220 - $11,780	1,000 Added 377.36%	1,265 $14,000
Q4 2021 Feb 14, 2022	SELL	$5.37 - $8.38 $660 - $1,030	-123 Reduced 31.7%	265 $2,000
Q3 2021 Nov 16, 2021	BUY	$7.36 - $13.67 $905 - $1,681	123 Added 46.42%	388 $3,000
Q1 2021 May 17, 2021	BUY	$3.2 - $16.51 $848 - $4,375	265 New	265 $3,000
Q4 2020 Feb 16, 2021	SELL	$2.92 - $4.84 $379 - $629	-130 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$3.53 - $6.17 $458 - $802	130 New	130 $1,000
Q4 2019 Feb 14, 2020	SELL	$11.58 - $17.37 $1,505 - $2,258	-130 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$13.19 - $28.36 $1,741 - $3,743	-132 Reduced 50.38%	130 $2,000
Q4 2018 Feb 13, 2019	BUY	$10.57 - $19.29 $1,902 - $3,472	180 Added 219.51%	262 $3,000
Q3 2018 Nov 15, 2018	BUY	$17.31 - $29.82 $1,419 - $2,445	82 New	82 $2,000

168

47.8M

130K

51K

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $608M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.